TrialBritish journal of cancer2012

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial.

Z Saridaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.